COVID-19: Cancer and screening services

Information on cancer and screening services during the COVID-19 response.

Page updated: 2 December 2021

On this page:


Cancer screening services

What you need to know about screening under the COVID-19 traffic light system (COVID-19 Protection Framework)

  • Cervical and breast screening will continue to be offered under the COVID-19 traffic light system (COVID-19 Protection Framework) as an essential service, with appropriate safeguards in place for participants and staff.  
  • Capacity for cervical screening and colposcopy (cervical) may be impacted at red and orange. Breast screening may be impacted at red. If your appointment needs to change, your health provider will contact you to reschedule. 
  • Bowel screening invitations and home testing kits will continue to be sent out. If you receive a kit in the mail, you should complete it. At orange and red, colonoscopies for those with a positive bowel screening test result may change. Please contact your DHB for additional information. 

Impact of COVID-19 on cancer services

Te Aho o Te Kahu, the Cancer Control Agency is monitoring the impact of COVID-19 on cancer services. Using available DHB data to rapidly measure the impact of COVID-19 restrictions on cancer care, these reports allow the Agency to track recovery and support DHBs.

The reports can be found on the Te Aho o Te Kahu website along with advice for clinicians on COVID-19 vaccines and cancer.

Back to top